EVOLOCUMAB

evolocumab 140 mg/mL injection, 1 mL pen device

EVOLOCUMAB (11484K)

evolocumab 140 mg/mL injection, 1 mL pen device
11484K
Body System:
Manner of administration:Injection
General Schedule
Authority Required (STREAMLINED)

Restriction  16294

Indication: Familial heterozygous hypercholesterolaemia
Treatment phase: Initial treatment

Restriction  16351

Indication: Non-familial hypercholesterolaemia
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $437.80 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Repatha